EUVIMEDEUVIMED entdecken
Open Access

ALKBH5 promotes the progression of cisplatin-resistant oral squamous cell carcinoma by regulating FOXA1 expression via m6A RNA methylation

Ying Wang, Hui-Xin Yang, Yu-Jia Gu, Mei Tian, Qi-Feng Geng

DARU Journal of Pharmaceutical Sciences · 06.06.2026 · 34 (2)

DOI: 10.1007/s40199-026-00614-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 06.06.2026. Verfasst von Ying Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Fifth Outpatient Department, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University…. Hauptthemen laut MEDLINE: AlkB Homolog 5, RNA Demethylase, Carcinoma, Squamous Cell, Cisplatin, Drug Resistance, Neoplasm. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Oral squamous cell carcinoma (OSCC) accounts for the vast majority of oral cancer cases. Accumulating evidence has implicated both AlkB homolog 5 (ALKBH5) and forkhead box protein A1 (FOXA1) in the emergence of cisplatin resistance in OSCC. This study aimed to define their functional roles and elucidate the underlying molecular mechanisms. METHODS: The expression of ALKBH5, FOXA1, and YTHDF2 was assessed by qPCR and Western blot. Cisplatin-resistant cell lines (H357 CisR and SCC4 CisR) were established via stepwise dose escalation. To investigate key functional phenotypes, a series of assays were employed: CCK-8 for viability, colony formation for proliferation, and Transwell for migration and invasion. Bioinformatics (SRAMP, RM2Target) predicted m⁶A sites on FOXA1 and its binding with ALKBH5, which were validated by MeRIP-qPCR and RIP. FOXA1 mRNA stability was measured by actinomycin D assay. RESULTS: ALKBH5 and FOXA1 were upregulated in cisplatin-resistant OSCC, with FOXA1 essential for maintaining oncogenic phenotypes. Bioinformatic and biochemical analyses confirmed FOXA1 as a direct target of ALKBH5. ALKBH5 demethylates FOXA1 mRNA, stabilizing its transcript and enhancing its expression by inhibiting YTHDF2-mediated degradation. Functionally, ALKBH5 overexpression reversed the tumor-suppressive effects of FOXA1 knockdown. CONCLUSION: A-dependent demethylation of FOXA1 transcripts, highlighting the ALKBH5-FOXA1 axis as a promising therapeutic target for overcoming this resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkB Homolog 5, RNA DemethylaseCarcinoma, Squamous CellCisplatinDrug Resistance, NeoplasmHepatocyte Nuclear Factor 3-alphaMouth NeoplasmsHumansAntineoplastic AgentsCell Line, TumorCell MovementCell ProliferationEpitranscriptomeGene Expression Regulation, NeoplasticRNA MethylationRNA-Binding ProteinsAdenosine

Stichwörter der Autor:innen

ALKBH5Cisplatin-resistant oral squamous cell carcinomaFOXA1YTHDF2m6A RNA methylation

Substanzen

AlkB Homolog 5, RNA DemethylaseALKBH5 protein, humanAntineoplastic AgentsCisplatinFOXA1 protein, humanHepatocyte Nuclear Factor 3-alphaN-methyladenosineRNA-Binding ProteinsYTHDF2 protein, humanAdenosine

Autor:innen und Institutionen

  • The Fifth Outpatient Department, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, China.
  • The Fifth Outpatient Department, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, China. qifeng_Geng@163.com.

Zitieren

APA

Wang, Y., Yang, H. X., Gu, Y. J., Tian, M., & Geng, Q. F. (2026). ALKBH5 promotes the progression of cisplatin-resistant oral squamous cell carcinoma by regulating FOXA1 expression via m6A RNA methylation. DARU Journal of Pharmaceutical Sciences, 34(2). https://doi.org/10.1007/s40199-026-00614-0

Vancouver

Wang Y, Yang HX, Gu YJ, Tian M, Geng QF. ALKBH5 promotes the progression of cisplatin-resistant oral squamous cell carcinoma by regulating FOXA1 expression via m6A RNA methylation. DARU Journal of Pharmaceutical Sciences. 2026;34(2). doi:10.1007/s40199-026-00614-0

BibTeX
@article{Wang2026,
  author = {Wang, Ying and Yang, Hui-Xin and Gu, Yu-Jia and Tian, Mei and Geng, Qi-Feng},
  title = {ALKBH5 promotes the progression of cisplatin-resistant oral squamous cell carcinoma by regulating FOXA1 expression via m6A RNA methylation},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {34},
  number = {2},
  doi = {10.1007/s40199-026-00614-0}
}
Kostenlos starten →